| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Chimerix Inc (NASDAQ: CMRX)
CMRX Technical Analysis
5
| As on 9th Jun 2023 CMRX STOCK Price closed @ 1.39 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 3.48 & Strong Sell for SHORT-TERM with Stoploss of 5.88 we also expect STOCK to react on Following IMPORTANT LEVELS. |
CMRXSTOCK Price
| Open | 1.38 | Change | Price | % |
| High | 1.43 | 1 Day | 0.01 | 0.72 |
| Low | 1.29 | 1 Week | 0.01 | 0.72 |
| Close | 1.39 | 1 Month | 0.26 | 23.01 |
| Volume | 958100 | 1 Year | -4.76 | -77.40 |
| 52 Week High 7.18 | 52 Week Low 1.10 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| CMRX Daily Charts |
CMRX Intraday Charts |
Whats New @ Bazaartrend |
CMRX Free Analysis |
|
|
CMRX Important Levels Intraday
| RESISTANCE | 1.66 |
| RESISTANCE | 1.57 |
| RESISTANCE | 1.52 |
| RESISTANCE | 1.47 |
| SUPPORT | 1.31 |
| SUPPORT | 1.26 |
| SUPPORT | 1.21 |
| SUPPORT | 1.12 |
CMRX Forecast May 2024
| 4th UP Forecast | 4.15 |
| 3rd UP Forecast | 3.26 |
| 2nd UP Forecast | 2.72 |
| 1st UP Forecast | 2.17 |
| 1st DOWN Forecast | 0.61 |
| 2nd DOWN Forecast | 0.06 |
| 3rd DOWN Forecast | -0.48 |
| 4th DOWN Forecast | -1.37 |
CMRX Weekly Forecast
| 4th UP Forecast | 2.82 |
| 3rd UP Forecast | 2.36 |
| 2nd UP Forecast | 2.08 |
| 1st UP Forecast | 1.79 |
| 1st DOWN Forecast | 0.99 |
| 2nd DOWN Forecast | 0.70 |
| 3rd DOWN Forecast | 0.42 |
| 4th DOWN Forecast | -0.04 |
CMRX Forecast2024
| 4th UP Forecast | 13.59 |
| 3rd UP Forecast | 9.68 |
| 2nd UP Forecast | 7.26 |
| 1st UP Forecast | 4.84 |
| 1st DOWN Forecast | -2.06 |
| 2nd DOWN Forecast | -4.48 |
| 3rd DOWN Forecast | -6.9 |
| 4th DOWN Forecast | -10.81 |
Chimerix Inc ( NASDAQ USA Symbol : CMRX )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
CMRX Business Profile
Chimerix, Inc., a development-stage biopharmaceutical company, focuses on accelerating the advancement of various medicines that impact in the lives of patients living with cancer and other serious diseases. Its clinical stage development programs include brincidofovir (BCV), an antiviral drug candidate in development as a medical countermeasure for smallpox; dociparstat sodium (DSTAT), which inhibits the activities of key proteins implicated in the resistance of acute myeloid leukemia blasts and leukemic stem cells to chemotherapy; and ONC201 a program for potentially treating tumors which harbor the H3 K27M mutation in recurrent diffuse midline glioma patients. The company has license agreements with Biomedical Advanced Research and Development Authority for the development of brincidofovir for use in the treatment of smallpox; Cantex Pharmaceuticals, Inc. to develop and commercialize a glycosaminoglycan compound; and SymBio Pharmaceuticals to develop, manufacture, and commercialize BCV for various human indications. Chimerix, Inc. was incorporated in 2000 and is headquartered in Durham, North Carolina. Address: 2505 Meridian Parkway, Durham, NC, United States, 27713
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service